Opnurasib
Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.
Product Specifications
CAS Number
2653994-08-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
526.03
Molecular Formula
C29H28ClN7O
Notes
Research use only, not for human use.
Receptor
Kras
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6011966-01 0.2 mL
DNER, CT (DNER, BET, Delta and Notch-like epidermal growth factor-related receptor)
Sign In for Pricing
View Details